Literature DB >> 27479688

Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft.

N Epperla1, M Pasquini1,2, K Pierce3, W R Drobyski2, J D Rizzo2, M M Horowitz2, W Saber2, K Zellner1, S Ramirez1, K Bartz1, R V Raj1, P N Hari1, M Hamadani1,2.   

Abstract

Mesh：

Year:  2016        PMID： 27479688     DOI： 10.1038/bmt.2016.200

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength.

Authors:  Thomas M Ellis; Jennifer J Schiller; Allan M Roza; David C Cronin; Brian D Shames; Christopher P Johnson
Journal:  Hum Immunol       Date:  2012-04-23       Impact factor: 2.850

2.  Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors.

Authors:  E W Petersdorf; G M Longton; C Anasetti; E M Mickelson; S K McKinney; A G Smith; P J Martin; J A Hansen
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

3.  Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.

Authors:  Takanori Teshima; Keitaro Matsuo; Kosei Matsue; Fumio Kawano; Shuichi Taniguchi; Masamichi Hara; Kazuo Hatanaka; Mitsune Tanimoto; Mine Harada; Shinji Nakao; Yasunobu Abe; Atsushi Wake; Tetsuya Eto; Yoshinobu Takemoto; Masahiro Imamura; Satoshi Takahashi; Yoji Ishida; Yoshinobu Kanda; Masaharu Kasai; Yoichi Takaue
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

4.  Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation.

Authors:  E A Copelan; T P Bechtel; B R Avalos; P J Elder; S A Ezzone; M D Scholl; S L Penza
Journal:  Bone Marrow Transplant       Date:  2001-06       Impact factor: 5.483

Review 5.  Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.

Authors:  Liang-Piu Koh; David A Rizzieri; Nelson J Chao
Journal:  Biol Blood Marrow Transplant       Date:  2007-11       Impact factor: 5.742

6.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

7.  Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.

Authors:  Yvette L Kasamon; Leo Luznik; Mary S Leffell; Jeanne Kowalski; Hua-Ling Tsai; Javier Bolaños-Meade; Lawrence E Morris; Pamela A Crilley; Paul V O'Donnell; Nancy Rossiter; Carol Ann Huff; Robert A Brodsky; William H Matsui; Lode J Swinnen; Ivan Borrello; Jonathan D Powell; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-18       Impact factor: 5.742

8.  High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

Authors:  Stefan O Ciurea; Marcos de Lima; Pedro Cano; Martin Korbling; Sergio Giralt; Elizabeth J Shpall; Xuemei Wang; Peter F Thall; Richard E Champlin; Marcelo Fernandez-Vina
Journal:  Transplantation       Date:  2009-10-27       Impact factor: 4.939

9.  Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.

Authors:  Abraham S Kanate; Alberto Mussetti; Mohamed A Kharfan-Dabaja; Kwang W Ahn; Alyssa DiGilio; Amer Beitinjaneh; Saurabh Chhabra; Timothy S Fenske; Cesar Freytes; Robert Peter Gale; Siddhartha Ganguly; Mark Hertzberg; Evgeny Klyuchnikov; Hillard M Lazarus; Richard Olsson; Miguel-Angel Perales; Andrew Rezvani; Marcie Riches; Ayman Saad; Shimon Slavin; Sonali M Smith; Anna Sureda; Jean Yared; Stefan Ciurea; Philippe Armand; Rachel Salit; Javier Bolaños-Meade; Mehdi Hamadani
Journal:  Blood       Date:  2015-12-15       Impact factor: 22.113

10.  Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.

Authors:  R F Olsson; B R Logan; S Chaudhury; X Zhu; G Akpek; B J Bolwell; C N Bredeson; C C Dvorak; V Gupta; V T Ho; H M Lazarus; D I Marks; O T H Ringdén; M C Pasquini; J R Schriber; K R Cooke
Journal:  Leukemia       Date:  2015-03-16       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.